Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients

Rajiv Shah, Aisha Baqai-Stern, Amitabh Gulati

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient’s disease course, and the management of complications related to the ITDD system and intrathecal medications.

Original languageEnglish
Article number20
JournalCurrent Pain and Headache Reports
Issue number6
StatePublished - Jun 30 2015


  • Cancer pain
  • Intrathecal drug delivery
  • Intrathecal medications
  • Neuraxial trial


Dive into the research topics of 'Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients'. Together they form a unique fingerprint.

Cite this